1. DOP081 Genital granulomatosis in Crohn's disease: results of the ECCO CONFER study. (16th January 2018) Authors: Dederichs, F; Iesalnieks, I; Sladek, M; Tzivinikos, C; Hansen, R; Muñoz, C; Pavli, P; Cavicchi, M; Abitbol, V; Rahier, J -F; Vavricka, S; Katsanos, K; Domènech, E Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. (17th March 2021) Authors: Kucharzik, T; Ellul, P; Greuter, T; Rahier, J F; Verstockt, B; Abreu, C; Albuquerque, A; Allocca, M; Esteve, M; Farraye, F A; Gordon, H; Karmiris, K; Kopylov, U; Kirchgesner, J; MacMahon, E; Magro, F; Maaser, C; de Ridder, L; Taxonera, C; Toruner, M Journal: Journal of Crohn's and colitis Issue: Volume 15:Number 6(2021) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce. (29th July 2020) Authors: Magro, F; Rahier, J-F; Abreu, C; MacMahon, E; Hart, A; van der Woude, C J; Gordon, H; Adamina, M; Viget, N; Vavricka, S; Kucharzik, T; Leone, S; Siegmund, B; Danese, S; Peyrin-Biroulet, L Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 3 Page Start: S798 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP037 Risk of cancer in inflammatory bowel disease patients is associated with age and recent use of immunomodulators, while biologics and aminosalicylates are protective factors: a cross-sectional and follow-up analysis of the Swiss IBD cohort study. (16th January 2018) Authors: Greuther, T; Scharl, S; Barthel, C; Rossel, J -B; Biedermann, L; Misselwitz, B; Vavricka, S; Rogler, G; Scharl, M Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P192 Extreme body mass indices are frequent in inflammatory bowel disease patients and are associated with higher disease activity in Crohn`s disease, but not in ulcerative colitis: a cross-sectional analysis of the Swiss IBD cohort study. (16th January 2018) Authors: Greuter, T; Porchet, F; Fournier, N; Biedermann, L; Schreiner, P; Scharl, M; Schoepfer, A; Safroneeva, E; Straumann, A; Rogler, G; Vavricka, S Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P285 A retrospective observational study on the effectiveness and safety of vedolizumab with or without budesonide induction therapy among patients with moderate-to-severe Crohn's disease. (27th May 2021) Authors: Weisshof, R; Vavricka, S; Pouillon, L; Braegger, F; Roset, M; Bent-Ennakhil, N; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P350 Real-world data regarding treatment of ulcerative colitis patients with golimumab in Switzerland. (25th January 2019) Authors: Perrig, K; Rossel, J-B; Biedermann, L; Schreiner, P; Roth, R; Zeitz, J; Greuter, T; Vavricka, S; Krupka, N; Juillerat, P; Rogler, G; Misselwitz, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P375 Inflammatory cutaneous lesions in inflammatory bowel disease treated with vedolizumab or ustekinumab: an ECCO CONFER multi-centre case series. (25th January 2019) Authors: Phillips, F M; Verstockt, B; Sebastian, S; Ribaldone, D G; Vavricka, S; Konstantinos, K; Slattery, E; de Suray, N; Flores, C; Fries, W; Vincenzi, F; Capoferro, E; Bachmann, O; Kopylov, U Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P406 A retrospective analysis of the efficacy of vedolizumab on extra-intestinal manifestations in patients with inflammatory bowel disease across five European countries. (27th May 2021) Authors: Kopylov, U; Burisch, J; Ben-Horin, S; Braegger, F; Fernández-Nistal, A; Lara, N; Vavricka, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P443 Systematic analysis of annual health resource utilisation and costs in hospitalised inflammatory bowel disease patients in Switzerland. (16th January 2018) Authors: Schoepfer, A; Vavricka, S; Bruengger, B; Reich, O; Blozik, E; Bähler, C Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗